Moleculin Biotech
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.08-0.090.360.08
Price/Sales ratio
0.480.230.410.19
Earnings per Share (EPS)
$-6.88$-6.02$1.63$7.07

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-60.61-5.70-3.52-2.26-2.82-3.14-5.64-1.10-0.85-0.60-2.54
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-60.911.492.011.882.392.650.630.580.970.492.52
Price/Cash Flow ratio
-107.10-5.95-4.71-2.20-2.16-2.64-2.63-1.09-1.05-0.63-2.18
Price/Free Cash Flow ratio
-107.10-5.91-4.69-2.13-2.16-2.59-2.63-1.09-1.05-0.63-2.14
Price/Earnings Growth ratio
N/A-0.02-0.100.170.090.140.07-0.00-0.170.010.12
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
236.75%N/A-11.74%-26.48%1.70%13.59%44.25%5.56%N/AN/A7.64%
Return on Assets
-2664.05%-23.95%-50.32%-60.63%-52.32%-51.65%-10.53%-47.73%-77.89%-74.30%-51.99%
Return On Equity
100.49%-26.24%-57.27%-83.21%-84.80%-84.43%-11.21%-52.51%-114.17%-68.37%-84.00%
Return on Capital Employed
99.13%-25.80%-50.11%-95.65%-80.88%-75.60%-28.54%-58.24%-94.36%-85.82%-78.24%
Liquidity Ratios
Current Ratio
N/A3.883.742.053.775.88N/AN/AN/A9.462.91
Quick Ratio
0.033.883.742.053.155.2520.029.463.858.952.60
Cash ratio
0.033.723.481.833.005.1919.578.953.458.952.42
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A4.35K2.38K-63.17-36.170.00N/A3.37K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A23.63K16.42K6.68K4.24K1.44K1.91K3.44K7.17KN/A2.84K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
16.010.01N/AN/AN/AN/AN/AN/AN/A0.09N/A
Debt Equity Ratio
-0.600.01N/AN/AN/AN/AN/AN/AN/A0.10N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
-1.520.01N/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/A-89.85N/AN/AN/AN/AN/AN/AN/A-396.03N/A
Cash Flow to Debt Ratio
-0.94-12.71N/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
-0.031.091.131.371.621.631.061.101.461.101.62
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.001.001.031.001.021.001.001.001.001.00
Cash Flow Coverage Ratio
-0.94-12.71N/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
-0.94-12.71N/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A